As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
The Indian diabetes market size reached a value of almost USD 1,957 million in the year 2019. The market is further expected to grow at a CAGR of 16.5% between 2020 and 2025 to reach a value of almost USD 4,892.7 million by 2025.
The Indian diabetes market is driven by the increasing obesity rates, accelerating stress levels, and lack of proper exercise in the country. The industry is aided by the support of the government of India, which is extending plans and initiatives to help control the damage done by the rising diabetes cases and is combating the situation by providing free insulin and treatment to diabetics at government hospitals.
Diabetes is referred to as a chronic disease which is caused by the sugar spikes in the body, as a result of inappropriate production of or response to insulin. Diabetes adversely impacts the body's ability to break down the sugar present in food, generate adequate insulin, or use insulin efficiently. If not brought under control, diabetes can cause a variety of complications, such as cardiovascular, visual, renal, and neural disorders.
The industry is segregated on the basis of segment into:
The Indian diabetes market is driven by the rising awareness among the consumers about the symptoms of diabetes, and its ill effects on health, which has majorly intensified the diagnosis and increased the drug treatment rates in the country. Rapid urbanisation and developing healthcare infrastructure are also aiding the industry growth of diabetes in India. In addition to this, extending pharmaceutical contract manufacturing, low-cost drug production, and the introduction of advanced technologies have further accelerated the industry growth of diabetes in India. However, the market growth might be hampered in the forecast period due to high research and development costs, technological developments that make the existing drugs obsolete or unmarketable, stringent pricing policy, price control, IPR (Intellectual Property Rights) protection, and regulatory approvals in terms of quality control.
The report gives a detailed analysis of the key players in the industry, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds. The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Indian Diabetes Market Snapshot
7 Industry Opportunities and Challenges
8 The Indian Diabetes Epidemiology
8.1 Diabetes Population and Prevalence Rates
8.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
8.3 Population and Prevalence Rates by Region (Urban and Rural)
8.4 Population and Prevalence Rates by Gender
8.5 Population and Prevalence Rates by Age Group
8.6 Diabetes Diagnosis and Drug Treatment Rates
9 Indian Diabetes Market Analysis
9.1 Key Industry Highlights
9.2 Indian Diabetes Historical Market (2015-2019)
9.3 Indian Diabetes Market Forecast (2020-2025)
9.4 Indian Diabetes Market by Segment
9.4.1 Indian Oral Antidiabetics
126.96.36.199 Market Share
188.8.131.52 Historical Trend (2015-2019)
184.108.40.206 Forecast Trend (2020-2025)
220.127.116.11 Market by Class
18.104.22.168 Market Shares of Key Players
9.4.2 Indian Insulin Market
22.214.171.124 Market Share
126.96.36.199 Historical Trend (2015-2019)
188.8.131.52 Forecast Trend (2020-2025)
184.108.40.206 Market by Class
220.127.116.11 Market Shares of Key Players
10 Indian Diabetes Diagnostics Market
10.1 Indian Diabetes Diagnostics Historical Market (2015-2019)
10.2 Indian Diabetes Diagnostics Market Forecast (2020-2025)
10.3 Indian Diabetes Diagnostics Market by Product Type
11 Market Dynamics
11.1 SWOT Analysis
11.2 Porter’s Five Forces Analysis
11.2.1 Supplier’s Power
11.2.2 Buyers Power
11.2.3 Threat of New Entrants
11.2.4 Degree of Rivalry
11.2.5 Threat of Substitutes
11.3 EMR’s Key Indicators for Demand
11.4 EMR’s Key Indicators for Price
12 Value Chain Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players’ Market Share
13.3 Key Players’ Profiles
13.3.1 Company Overview
13.3.2 Demographic Reach and Achievements
14 Industry Events and Developments
List of Figures and Tables
1. Indian Diabetes Market: Key Industry Highlights, 2015 and 2025
2. Indian Diabetes Historical Market: Breakup by Segment (USD Million), 2015-2019
3. Indian Diabetes Market Forecast: Breakup by Segment (USD Million), 2020-2025
4. Indian Diabetes Diagnostics Market: Key Industry Highlights, 2015 and 2025
5. Indian Diabetes Diagnostics Historical Market: Breakup by Product Type (USD Million), 2015-2019
6. Indian Diabetes Diagnostics Market Forecast: Breakup by Product Type (USD Million), 2020-2025
7. Indian Diabetes Market Structure
The Indian diabetes market reached a value of USD 1,957 million in 2019.
The market is projected to grow at a CAGR of nearly 16.5% in the forecast period of 2020-2025.
The market is estimated to reach a value of about USD 4,892.7 million by 2025.
The major drivers of the industry include rising disposable incomes, increasing population, rapid urbanisation, rising awareness among the consumers, increasing pharmaceutical contract manufacturing, low-cost drug production, the introduction of advanced technologies, and the growing healthcare infrastructure.
The rising support of the government of India, through plans and initiatives to help control the damage done by the rising diabetes cases by providing free insulin and treatment to diabetics at government hospitals is expected to be a key trend guiding the growth of the industry.
The major segments can be divided into Indian oral antidiabetics and the Indian insulin market.
The Indian diabetes market attained a value of USD 1,957 million in 2019, driven by the rising awareness among consumers. Aided by the advancements in technologies, the industry is expected to witness a further growth in the forecast period of 2020-2025, growing at a CAGR of 16.5%. The industry is projected to reach USD 4,892.7 million by 2025.
EMR's meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. Based on its segments, the industry can be segmented into Indian oral antidiabetics and the Indian insulin market.
EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with industry insights that are accurate, actionable, and help them remain ahead of their competition.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.